Cardinal Health (CAH)
NYSE Market Closed
Cardinal Health, Inc. is a major healthcare services and products company best known for its role in the US pharmaceutical supply chain. The company buys, stores, and distributes prescription medicines, including branded drugs, generics, specialty therapies, and over-the-counter healthcare products, to pharmacies, hospitals, health systems, physician offices, and other care providers. Alongside McKesson and Cencora, Cardinal Health is part of the small group of wholesalers that handles the vast majority of pharmaceutical distribution in the United States.
Its scale is central to the business model. Cardinal Health operates high-volume logistics networks that help manufacturers reach customers efficiently while giving healthcare providers reliable access to medicines and related services. The company also supports pharmacies with inventory management, data tools, reimbursement support, and programmes designed to improve purchasing efficiency and patient care.
Cardinal Health’s operations extend beyond drug distribution. Its medical segment supplies healthcare facilities with medical-surgical products, laboratory supplies, procedure kits, and other equipment used in clinical settings. The company has served customers across North America and also participates in international healthcare markets, including parts of Europe and Asia.
For investors, Cardinal Health is typically viewed as a scale-driven healthcare distributor with large revenue volumes, thin margins, and close links to trends in drug utilisation, generic pricing, specialty pharmaceuticals, hospital demand, and healthcare regulation. Its position in a highly consolidated industry gives it important purchasing and distribution reach, while its exposure to medical products adds another channel into hospitals and care providers.
Last updated
- Market Cap
- 47.25B
- P/E
- 30.39
- P/FCF
- 10.76
- P/S
- 0.19
- Enterprise Value
- 52.23B
- Sector
- Health Care
- Industry
- Drugs, Drug Proprietaries, and Druggists' Sundries
- Address
- 7000 CARDINAL PLACE, DUBLIN, OH, 43017
Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032
3 Dividend Stocks With High Returns on Invested Capital
United States Personal Protective Equipment (Gowns, Masks, Face Shields and Others) Market Outlook to 2033
AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies
Pharmaceutical Waste Management Market is expected to generate a revenue of USD 2631.59 Million by 2032, Globally, at 5.91% CAGR: Verified Market Research®
Adhesive Bandages Market is expected to generate a revenue of USD 4.48 Billion by 2032, Globally, at 3.60% CAGR: Verified Market Research®
Increasing medication access: Charitable clinics and pharmacies to receive share in $1.6 million in Equity Rx grants from Cardinal Health Foundation
Telepharmacy Market Size to Reach US$ 21.89 Billion By 2032, Bridges Rural–Urban Healthcare Gap and Expands Digital Pharmacy Access | S&S Insider
Cell and Gene Therapy Third-Party Logistics Market Forecast and Company Analysis Report 2025-2033 Featuring Cencora, Cardinal Health, McKesson, EVERSANA, Knipper Health, Arvato, DHL, and Kuehne+Nagel
Burns Market Analysis and Forecast Report 2025-2035 Featuring Pfizer, Perrigo, Kenvue Brands, 3M, Smith+Nephew, Molnlycke, Cardinal Health, Convatec, Haleon, Coloplast, DeRoyal Industries
Continence Care Market Size to Surpass USD 9.54 Billion by 2031 With 5.6% CAGR, Surging Prevalence of Chronic Diseases Propels the Demand | The Insight Partners
Healthcare Cold Chain Logistics Market Report 2025-2035 | High Costs of Cold Storage and Transportation Pose Challenges for Healthcare Logistics
Global Prefilled Syringes Market to Cross USD 28 Billion by 2032 | DelveInsight
Antiseptics and Disinfectants Market Size to Worth USD 100.89 billion by 2033, at a CAGR of 9.5% | Straits Research
Surgical Gown Market is Set to Grow at a 5.4% CAGR, Projected to Reach US$ 2,734.7 Million by 2034 | Fact.MR Report
Surgical Drapes Market to Worth Over US$ 3,766.0 Million By 2033 | Drape Sheets to Control Highest Revenue Share Says Astute Analytica
Wound Closure Devices Market Insights, Competitive Landscape and Market Forecast to 2030
Medical Nonwoven Market is Forecasted to Reach US$ 2.1 Billion in 2030, Says Stratview Research
Urinary Drainage Bags Market to Witness 4.9% CAGR by 2031 | SkyQuest Technology
GI Alliance to Partner with Cardinal Health Creating a Scaled Multi-Specialty Managed-Services Platform to Benefit Physicians and Patients
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 47.25B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 52.23B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 30.39
- P/B
P/B ratio compares a company's share price to its book value per share.
- -16.68
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 0.19
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 13.11
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 0.21
- EPS
- 6.64
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 1.04%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 10.76
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 9.43
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 4.39B
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- -54.91%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 2.74%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- -3.15
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 0.91
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 0.48
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 0.09
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 2.34M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 201.74
Income Statement
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Revenue | 60.94B | 65.63B | 64.01B | 60.16B | 54.88B |
| Gross profit | 2.5B | 2.4B | 2.32B | 2.2B | 2.12B |
| Operating income | 694M | 707M | 670M | 428M | 713M |
| EBITDA | 978M | 930M | 923M | 1.15B | 843M |
| Net income | 399M | 467M | 450M | 239M | 506M |
| Basic EPS | 1.69 | 1.98 | 1.89 | 1.01 | 2.11 |
| Diluted EPS | 1.69 | 1.97 | 1.88 | 1.01 | 2.1 |
Balance Sheet
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total assets | 56.69B | 58.08B | 55.23B | 53.12B | 49.87B |
| Total liabilities | 59.36B | 60.78B | 57.96B | 55.76B | 51.77B |
| Total equity | -2.67B | -2.7B | -2.73B | -2.63B | -1.9B |
| Cash & equivalents | 3.94B | 2.78B | 4.59B | 3.87B | 3.33B |
| Current assets | 38.06B | 39.23B | 38.54B | 36.37B | 34.6B |
| Current liabilities | 41.99B | 43.31B | 40.27B | 38.9B | 36.66B |
Cash Flow
| Line Item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating cash flow | 1.82B | 686M | 973M | 1.53B | 2.92B |
| Investing cash flow | -181M | -1.98B | -142M | -1.63B | -2.9B |
| Financing cash flow | -483M | -519M | -110M | 656M | -510M |
| Change in cash | 1.16B | -1.82B | 719M | 548M | -484M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | SD — CARDINAL HEALTH INC | View Filing | |
| edgar index | SCHEDULE 13G — CARDINAL HEALTH INC | View Filing | |
| edgar index | SCHEDULE 13G — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| form 4 | Form 4 — Hall Patricia Hemingway | View Filing | |
| edgar index | SCHEDULE 13G/A — CARDINAL HEALTH INC | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 144 — CARDINAL HEALTH INC | View Filing | |
| form 4 | Form 4 — Greene Michelle D. | View Filing | |
| form 4 | Form 4 — Greene Michelle D. | View Filing | |
| edgar index | 144 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| form 4 | Form 4 — Alt Aaron E | View Filing | |
| form 4 | Form 4 — Alt Aaron E | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 144 — CARDINAL HEALTH INC | View Filing | |
| form 4 | Form 4 — Hall Patricia Hemingway | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| edgar index | 10-Q — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G/A — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| form 4 | Form 4 — Pitteroff Valerie Christine | View Filing | |
| form 4 | Form 4 — Pitteroff Valerie Christine | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 3 — CARDINAL HEALTH INC | View Filing | |
| form 3 | Form 3 — Pitteroff Valerie Christine | View Filing | |
| form 3 | Form 3 — Pitteroff Valerie Christine | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| form 4 | Form 4 — Snow Ola M | View Filing | |
| form 4 | Form 4 — Snow Ola M | View Filing | |
| form 4 | Form 4 — Mayer Jessica L | View Filing | |
| form 4 | Form 4 — Mason Stephen M | View Filing | |
| form 4 | Form 4 — WEITZMAN DEBORAH | View Filing | |
| form 4 | Form 4 — Scherer Mary C. | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| edgar index | 4 — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| form 4 | Form 4 — MUNDKUR CHRISTINE | View Filing | |
| form 4 | Form 4 — KENNY GREGORY B | View Filing | |
| form 4 | Form 4 — Evans David C | View Filing | |
| form 4 | Form 4 — Musslewhite Robert W | View Filing | |
| form 4 | Form 4 — Edison Sheri H. | View Filing | |
| form 4 | Form 4 — Ramakrishna Sudhakar | View Filing | |
| form 4 | Form 4 — JOHRI AKHIL | View Filing | |
| form 4 | Form 4 — Hall Patricia Hemingway | View Filing | |
| form 4 | Form 4 — Killefer Nancy | View Filing | |
| form 4 | Form 4 — Azelby Robert | View Filing | |
| form 4 | Form 4 — Brennan Michelle | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| edgar index | 10-Q — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — CARDINAL HEALTH INC | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | 8-K — CARDINAL HEALTH INC | View Filing |